SPDR SSGA Multi-Asset Real Return ETF (RLY)
ARCA ARCA Primary Summary
RLY Chart
Relay Therapeutics: A Precision Oncology Play Worth The Risk
Relay Therapeutics focuses on selective small-molecule inhibitors, with RLY-2608 showing promise in breast cancer and a solid cash position lasting into 2027. Financial stability is strong, but zero Q3 2024 revenue and rising net losses raise concerns about expense control and sustainable cash flow. Out-licensing RLY-4008 to Elevar Therapeutics secures up to $500 million in milestones, allowing RLAY to concentrate on RLY-2608's clinical trials.
Relay Therapeutics: 2nd-Line RLY-2608 Data Moves Program Towards Expansion
Relay Therapeutics, Inc. reported positive interim data from its phase 1 ReDiscover study, using RLY-2608 + fulvestrant for treatment of PI3Ka-mutated HR+/HER2- locally advanced or metastatic breast cancer patients. Key upcoming milestones for RLY-2608 program includes presenting data at the San Antonio Breast Cancer Symposium in December 2024 and initiating a phase 3 study in 2025. Expansion opportunities of the RLY-2608 program includes two triplet regimens targeting 1st-line PI3Ka-mutant HR+/HER2- breast cancer patients and phase 1 study for tumors with vascular formations starting in Q1 2025.
Relay Therapeutics' RLY-2608 Shows Promise For Breast Cancer With PI3Kα Mutations
Relay Therapeutics' Dynamo platform combines machine learning and physics-based simulation to target dynamic protein conformations for oncology and genetic disease therapies. RLY-2608 targets PI3Kα-mutated HR+/HER2- breast cancer, with promising Phase 2 results and potential approval by 2026-2027. The company's RLY-4008 targets FGFR2-altered cholangiocarcinoma, and it is seeking pivotal trials and a commercialization partner to unlock broader market potential.
SPDR SSGA Multi-Asset Real Return ETF Dividends
| RLY In 3 months Estimated | Other | $0.25 Per Share |
| RLY 1 month ago Paid | Other | $0.25 Per Share |
| RLY 7 months ago Paid | Quarterly | $0.44 Per Share |
| RLY 10 months ago Paid | Quarterly | $0.08 Per Share |
| RLY 25 Jun 2024 Paid | Quarterly | $0.35 Per Share |
| RLY 19 Mar 2024 Paid | Quarterly | $0.03 Per Share |
SPDR SSGA Multi-Asset Real Return ETF Earnings
| RLY In 3 months Estimated | Other | $0.25 Per Share |
| RLY 1 month ago Paid | Other | $0.25 Per Share |
| RLY 7 months ago Paid | Quarterly | $0.44 Per Share |
| RLY 10 months ago Paid | Quarterly | $0.08 Per Share |
| RLY 25 Jun 2024 Paid | Quarterly | $0.35 Per Share |
| RLY 19 Mar 2024 Paid | Quarterly | $0.03 Per Share |
SPDR SSGA Multi-Asset Real Return ETF (RLY) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has SPDR SSGA Multi-Asset Real Return ETF ever had a stock split?
SPDR SSGA Multi-Asset Real Return ETF Profile
| ARCA Exchange | US Country |
Overview
The company appears to specialize in investment management with a clear focus on diversifying its investment portfolio across various asset classes to hedge against inflation and capitalize on potential growth opportunities. The strategic allocation towards a mix of inflation-protected securities, real estate, commodities, infrastructure, and natural resources companies underlines a comprehensive approach to asset management. By investing in Exchange-Traded Products (ETPs) that provide exposure to these asset classes, the company aims to offer investors a blend of income generation, capital appreciation, and inflation protection. This strategy signifies a robust investment framework designed to navigate through varying economic environments while seeking sustainable returns.
Products and Services
- Inflation Protected Securities:
Investments in securities issued by the United States government that are designed to protect against inflation. This typically involves Treasury Inflation-Protected Securities (TIPS), which adjust in response to inflation as measured by the Consumer Price Index, thereby offering a real rate of return guaranteed by the U.S. government.
- Real Estate Securities:
Focusing on both domestic and international real estate securities, the company invests in stocks or ETPs related to the real estate market. This can include investments in Real Estate Investment Trusts (REITs) which provide exposure to commercial, residential, and industrial real estate sectors, offering potential income through dividends and capital appreciation.
- Commodities:
Exposure to commodities through ETPs allows the company to invest in physical commodities like metals, energy, and agricultural products or in commodity-related companies. This diversification helps in hedging against inflation and taking advantage of growth in the commodity markets.
- Infrastructure Companies:
Investments in publicly-traded domestic and international infrastructure companies. These can include enterprises involved in the construction, management, or operation of infrastructure assets such as roads, bridges, ports, and utilities. Infrastructure investments often provide stable cash flows and have a potential inflation protection component.
- Natural Resources and Commodities Businesses:
Focusing on publicly-traded companies involved in the natural resources sector or commodities businesses. This can include enterprises engaged in the extraction, production, or sale of natural resources like oil, gas, metals, and minerals. Investments in this area often seek to leverage growth in the global demand for natural resources.
Contact Information
